PCB’s Semiconductor Orders Add Circuit-Board Backlog, With Margin and Collection Setting the Value
PCB reported about EUR 8.6 million of orders from a European semiconductor-equipment customer on June 15. The orders create a near-term revenue path, while the real value will depend on margin, inventory, receivables and repeat demand.
P.C.B. reported on June 15 that it received several orders from a leading European customer in the semiconductor equipment industry for about EUR 8.6 million. The products are dozens of types of printed circuit boards that will later be installed in a critical system used by the global semiconductor industry, with deliveries expected to begin in the third quarter and continue through the first quarter of 2027. The filing changes the way to read P.C.B.'s chip exposure because the orders enter the printed circuits and substrates plant, not only the miniaturization activity that already appeared in prior reports. That is a real business signal: an existing European customer is expanding work with the company, and the delivery window is relatively near. The economic value still depends on three undisclosed items: the margin on the work, the inventory and procurement required before delivery, and the pace of customer collection. If the orders become revenue without a disproportionate increase in receivables and bank credit, they strengthen the case that chip exposure is becoming commercial activity. If they come with low margins, delivery delays or wide customer credit, they remain interesting backlog with limited cash value.
The Orders Belong to the Circuit-Board Plant
The most important detail in the filing is not only the order amount. P.C.B. placed the orders in the printed circuits and substrates division, not in the electronic systems miniaturization segment. That changes the interpretation: semiconductor exposure is not limited to the small and fast-growing miniaturization business, but is also entering the more established activity of advanced circuit boards and substrates.
The company describes the orders as dozens of different types of printed circuit boards. The customer is a leading European semiconductor-equipment customer, and the boards will be integrated into a critical system used by the global chip industry. Another detail improves the quality of the relationship: the company already sells additional products to the same customer beyond the products included in the new orders. This is not generic exposure to the sector through a presentation or marketing plan. It is a set of orders received during the two weeks before June 12.
The weaker part of the filing sits in the terms that are not disclosed. P.C.B. does not disclose the customer's name, unit pricing, expected margin, payment terms or the exact delivery split by quarter. The company also states that total consideration and delivery timing may change because of changes in product quantities ordered by the customer, component-price changes, cancellations under the agreed terms or delays. The orders therefore improve revenue visibility, but still do not say enough about profit quality or cash collection.
EUR 8.6 Million Changes the Near-Term Delivery Backlog
The new number matters mainly because of the company's starting point. In the first quarter of 2026, P.C.B. reported revenue of USD 46.1 million, including USD 20.1 million of printed circuits and substrates revenue including intersegment sales. The group's backlog near the publication of the quarterly reports was about USD 136 million, and backlog plus expected orders totaled about USD 177 million. Printed circuits and substrates accounted for about USD 83 million of that backlog and expected-orders total.
An EUR 8.6 million order does not turn the entire company into a semiconductor company, and it does not replace its defense, medical and industrial activity base. Its significance is more focused: it adds near-term delivery work from a European chip-equipment customer while the company is already trying to expand its international activity. In the circuit-board plant, where the average delivery time for ordinary orders is around six weeks, a delivery schedule from the third quarter through the following first quarter points to a multi-quarter supply sequence rather than a one-off inventory correction.
The link to the previous Deep TASE chip map matters here. P.C.B. appeared there as a value-chain supplier, not a pure semiconductor company. The new filing does not erase that distinction. It does move part of the exposure from a mapping exercise into orders intended for a system used by a semiconductor-equipment customer. The next question is therefore not only whether the company "belongs" in the chip discussion, but whether this work shows up in the accounts as growth with reasonable margin and good collection.
Inventory, Receivables and Bank Credit Will Decide Backlog Quality
For P.C.B., backlog is not enough without a balance-sheet check. At the end of the first quarter, receivables stood at USD 54.9 million, compared with USD 42.3 million in the comparable quarter, with the company attributing the change to activity growth, sales timing and customer mix. Inventory stood at USD 37.9 million, and the company tied the change to inventory timing and customer mix. At the same date, the company had used USD 17.1 million of USD 18.5 million in credit facilities, with bank credit used both for ongoing activity and for investments in upgrading production systems.
The new orders have to pass through that same system. Producing dozens of types of circuit boards for a chip-equipment customer can improve production-line utilization and add a higher-quality customer to the mix. It can also require component procurement, inventory holding and customer credit before cash is collected. That makes gross margin and the balance sheet over the next few quarters more important than the order amount alone.
There is a positive starting point. In the first quarter, operating cash flow was USD 3.0 million, compared with USD 1.5 million in the comparable quarter, and miniaturization gross profit rose to USD 1.4 million from USD 472 thousand. On the other side, investing cash flow was negative USD 3.9 million, and the company continued investing in improving and upgrading its production systems. A high-quality chip order should show up in the next reports not only in sales, but also in inventory, receivables and bank credit not growing faster than the operating contribution.
Tower Adds Sector Context, PCB Has to Show Repeat Demand
On the same June 15 date, TOWER and IQE announced a multi-year agreement for InP epiwafers, indium phosphide wafers used in optical photonics, for TOWER's silicon photonics platforms. The agreement includes a minimum first-year purchase commitment by TOWER, a reciprocal supply commitment by IQE and minimum volume commitments thereafter. A separate patent-license agreement settles the companies' intellectual-property disputes.
The TOWER event proves nothing about P.C.B.'s revenue. It does provide sector context: one part of the chain is securing material supply and licensing around optical photonics, while an Israeli circuit-board supplier is receiving orders from a European chip-equipment customer. For TOWER, the filing is about future platforms. For P.C.B., the filing is already about work that is supposed to become revenue over the next few quarters.
The next read is clear. P.C.B. has to show that the orders enter reported backlog, deliveries begin on schedule, margin in printed circuits and substrates does not erode, and inventory and receivables do not absorb the new contribution. The June 15 order strengthens the company's link to the Israeli and European chip chain. Its value will be decided when it becomes revenue, gross profit and cash collection, not just another backlog number.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.